<DOC>
	<DOCNO>NCT02912988</DOCNO>
	<brief_summary>In-vitro fertilization ( IVF ) treatment choice couple prolong infertility . The treatment usually involve hormonal stimulation ovary follicle stimulate hormone ( FSH ) , follow surgical removal egg mixed sperm laboratory create embryo . The success rate IVF treatment remain unsatisfactory long increase . One reason adverse effect high serum estradiol level follow FSH stimulation line uterus . Letrozole drug use prevention recurrence breast cancer action reduce intra-ovarian aromatization androgen estrogens . It increasingly use ovulation induction safe clomiphene citrate . Use letrozole standard ovarian stimulation IVF produce adequate number oocytes physiological level estradiol may increase present success rate standard IVF treatment . The aim randomize study compare live birth rate FSH alone versus combine FSH letrozole use ovarian stimulation IVF treatment .</brief_summary>
	<brief_title>Letrozole Stimulated IVF Cycles</brief_title>
	<detailed_description>Trial design : Infertile woman undergo IVF treatment randomize one follow two group online randomization program : Letrozole group : letrozole 2.5mg daily give start antagonist ovarian stimulation i.e . day 5 stimulation . Control group : standard care FSH alone ovarian stimulation . Intervention : Subjects put oral contraceptive pill precede cycle schedule stimulation . On day 2-3 , pelvic ultrasound perform antral follicle count . Letrozole group : Daily 150-300 IU human menopausal gonadotrophin ( HMG ) / Follicle stimulate hormone ( FSH ) cycle day 2-4 ( least 5 day stop oral contraceptive pill ) co-treatment letrozole 2.5 mg daily stimulation day 5 day hCG administration . GnRH antagonist ( cetrotide orgalutran ) 0.25 mg daily stimulation day 5 day hCG administration . Control group : Daily 150-300 IU HMG/FSH cycle day 2-4 ( least 5 day stop oral contraceptive pill ) day hCG administration . GnRH antagonist 0.25 mg daily stimulation day 5 day hCG administration . - 150 IU HMG/FSH woman AFC &gt; 15 - 225 IU HMG/FSH AFC 5-15 - 300 IU HMG/FSH AFC &lt; 5 A blood sample take analyzed local laboratory serum E2 , P testosterone level cycle day 2 3 ( baseline ) day hCG ( day ) . The remain serum frozen store late analysis . A sample follicular fluid ( FF ) collect first blood free follicle . The FF frozen store late analysis : Estradiol , testosterone , inhibin B AMH level . All technique IVF include harvest oocyte , insemination specially prepared sperm , embryo culture laboratory , embryo transfer luteal phase support accord local protocol . One two embryo blastocyst replace . A pregnancy test carry 2 week embryo transfer arm . All woman positive pregnancy test 2 week embryo transfer undergo transvaginal ultrasound scan identify presence number gestation sac fetal heart signify ongoing pregnancy . Pelvic scan repeat 8 week , 12 week , 24 week 36 week gestation fetal growth .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>woman 42 year age medical indication IVF treatment antral follicle count prior ovarian stimulation &gt; =3 inform consent woman use donor oocyte woman undergo preimplantation genetic diagnosis woman abnormal uterine cavity show hysterosalpingogram saline infusion sonogram woman hydrosalpinges show scan correct previous document poor response ( &lt; =3 oocyte ) ovarian stimulation use least FSH 225 IU daily</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Subfertility</keyword>
	<keyword>In-vitro fertilization</keyword>
	<keyword>Letrozole</keyword>
</DOC>